Persistent Atrial Fibrillation (AF) APAC (Asia Pacific) Observational Study (PerAF APAC)
Persistent AF (Asia Pacific) Observational Study
Sponsor: Abbott Medical Devices
Terminated
The study was terminated early by the Sponsor as sufficient data had been collected to satisfy the study objectives.
Other terminated trials from Abbott Medical Devices
Other Persistent Atrial Fibrillation trials with similar outcome
Listed as NCT04244396, this observational or N/A phase trial focuses on Persistent Atrial Fibrillation and remains terminated or withdrawn. Sponsored by Abbott Medical Devices, it has been updated 10 times since 2020, reflecting substantial change activity. This study contributes longitudinal data to the cardiovascular research landscape.
Status Flow
Change History
10 versions recorded-
Sep 2025 — Present [monthly]
Terminated
-
Sep 2024 — Sep 2025 [monthly]
Terminated
-
Jul 2024 — Sep 2024 [monthly]
Terminated
-
May 2024 — Jul 2024 [monthly]
Terminated
-
Feb 2023 — May 2024 [monthly]
Terminated
Status: Active Not Recruiting → Terminated
▶ Show 5 earlier versions
-
Jul 2022 — Feb 2023 [monthly]
Active Not Recruiting
Status: Recruiting → Active Not Recruiting
-
Sep 2021 — Jul 2022 [monthly]
Recruiting
-
Jan 2021 — Sep 2021 [monthly]
Recruiting
-
Apr 2020 — Jan 2021 [monthly]
Recruiting
Status: Not Yet Recruiting → Recruiting
-
Feb 2020 — Apr 2020 [monthly]
Not Yet Recruiting
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Abbott Medical Devices
For direct contact, visit the study record on ClinicalTrials.gov .